Gam-COVID-Vac (Sputnik V)

Development status

1. Emergency use/conditional marketing authorizations granted in multiple countries
   
2. Phase 3 clinical trials underway in Belarus, the United Arab Emirates, Venezuela and India

Emergency use
authorizations granted in:

Drugs to Watch - Gam-COVID-Vac

Distribution

The vaccine is well-tolerated and easily administered.

With a reported 91.6% efficacy when administered per protocol but it does require storage at freezer temperatures.